1,2,2-TRIMETHYL-3-(4-METHYL-PIPERAZINE-1-CARBONYL)-CYCLOPENTANECARBOXYLIC ACID
- $378 - $874
- Product name: 1,2,2-TRIMETHYL-3-(4-METHYL-PIPERAZINE-1-CARBONYL)-CYCLOPENTANECARBOXYLIC ACID
- CAS: 94372-90-4
- MF: C15H26N2O3
- MW: 282.38
- EINECS:
- MDL Number:MFCD03701713
- Synonyms:TIMTEC-BB SBB012229;1,2,2-TRIMETHYL-3-(4-METHYL-PIPERAZINE-1-CARBONYL)-CYCLOPENTANECARBOXYLIC ACID;1,2,2-trimethyl-3-((4-methylpiperazin-1-yl)carbonyl)cyclopentanecarboxylic acid;Cyclopentanecarboxylic acid, 1,2,2-trimethyl-3-[(4-methyl-1-piperazinyl)carbonyl]-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0082958
- Product description1,2,2-TRIMETHYL-3-(4-METHYL-PIPERAZINE-1-CARBONYL)-CYCLOPENTANECARBOXYLIC ACID 95.00%
- Packaging500MG
- Price$762.3
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11007299
- Product description1,2,2-Trimethyl-3-(4-methylpiperazine-1-carbonyl)cyclopentanecarboxylicacid 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number008604
- Product description1,2,2-Trimethyl-3-(4-methyl-piperazine-1-carbonyl)-cyclopentanecarboxylic acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0082958 | 1,2,2-TRIMETHYL-3-(4-METHYL-PIPERAZINE-1-CARBONYL)-CYCLOPENTANECARBOXYLIC ACID 95.00% | 500MG | $762.3 | 2021-12-16 | Buy |
Crysdot | CD11007299 | 1,2,2-Trimethyl-3-(4-methylpiperazine-1-carbonyl)cyclopentanecarboxylicacid 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 008604 | 1,2,2-Trimethyl-3-(4-methyl-piperazine-1-carbonyl)-cyclopentanecarboxylic acid | 1g | $378 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|